Tag Archives: 340B

What’s Next for Diplomat Pharmacy After Poor Results in Q2 2019?

Diplomat’s core specialty pharmacy performance is being negatively impacted by increased competition

Genentech Distribution Decision

This is an example of a pharmaceutical company helping another group of healthcare stakeholders, health plans, because of an issue with health systems increasing cost of care. Stakeholders in the healthcare market, while working to reduce the cost of care, are trying to determine the best path to profitability. An example is Genentech’s decision to […]